BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lei GL, Niu Y, Cheng SJ, Li YY, Bai ZF, Yu LX, Hong ZX, Liu H, Liu HH, Yan J, Gao Y, Zhang SG, Chen Z, Li RS, Yang PH. Upregulation of long noncoding RNA W42 promotes tumor development by binding with DBN1 in hepatocellular carcinoma. World J Gastroenterol 2021; 27(20): 2586-2602 [PMID: 34092977 DOI: 10.3748/wjg.v27.i20.2586] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan A, Zhang X. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 2022;9:406. [DOI: 10.3390/bioengineering9080406] [Reference Citation Analysis]
2 Wang Q, Fang Q, Huang Y, Zhou J, Liu M. Identification of a novel prognostic signature for HCC and analysis of costimulatory molecule-related lncRNA AC099850.3. Sci Rep 2022;12:9954. [PMID: 35705628 DOI: 10.1038/s41598-022-13792-z] [Reference Citation Analysis]
3 Jiang B, Yang K, Tang C, Chen R, Wang C. LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axis. Bioengineered 2022;13:8994-9005. [PMID: 35345980 DOI: 10.1080/21655979.2022.2054204] [Reference Citation Analysis]
4 Yang Y, Li Y, Yuan H, Liu X, Ren Y, Gao C, Jiao T, Cai Y, Zhao S. Integrative Analysis of the lncRNA-Associated ceRNA Regulatory Network Response to Hypoxia in Alveolar Type II Epithelial Cells of Tibetan Pigs. Front Vet Sci 2022;9:834566. [DOI: 10.3389/fvets.2022.834566] [Reference Citation Analysis]
5 Lu J, Xiao Z, Xu M, Li L. New Insights into LINC00346 and its Role in Disease. Front Cell Dev Biol 2021;9:819785. [PMID: 35096842 DOI: 10.3389/fcell.2021.819785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pan G, Zhang J, You F, Cui T, Luo P, Wang S, Li X, Yuan Q. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1. Bioengineered 2022;13:1346-58. [PMID: 34983308 DOI: 10.1080/21655979.2021.2017565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]